chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; muscle pain; chest pain; This is a spontaneous report from a contactable consumer or other non hcp.   A 27-years-old female (pregnant unknown) patient received bnt162b2 (BNT162B2, solution for injection, Lot Number: EL3249), via an unspecified route of administration, administered in right arm on 10Mar2021 09:30 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included pulmonary embolism, asthma. Concomitant medication included albuterol (salbutamol) taken for an unspecified indication.  Patient had no known allergies. The patient did not receive any other vaccines in four weeks and any other medications in two weeks. Patient was not tested for covid prior or post vaccination. On 10Mar2021 15:00, the patient experienced fatigue, muscle pain, chest pain. The clinical outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to three unspecified patients of unknown age. On 04-AUG-2014 the three patient was inadvertently vaccinated with expired doses of RECOMBIVAX HB intramuscular. Lot# was 1741AA, and the vaccine was expired on 27-JUN-2014. No adverse effects reported. Follow up information was received from the medical assistant. The reporter provided the patient identifiers with the name and date of birth. This report refers to a 8 week old patient of unknown gender. This case is linked to 1408USA002323 (same reporter link). Additional information has been requested.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose02/05/21 2nd dose02/26/21 Diagnosed covid positive:09/13/21 Symptom onset:09/13/21 Exposure:travel Symptoms:Cough,fatighue,chills,runnynose,HA
12hrs after shot- experienced fever chills and discomfort, lasted 4 days, then experienced vertigo for 3 days, then experienced extreme overwhelming pain in abdomen and extremities for 5 days
The patient reported that after her first dose, a little up her arm towards the back, not where they put the shot, she had a bump that hurt when she touched it. She further stated that it went away. The patient received the second dose on 17Apr2021. The clinical outcomes of a little up her arm towards the back she had a bump that hurt when she touched it were recovered on unspecified dates.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient is a 95 y.o. male who presented from  independent living  on 3/2/2023 with hypoxia, and he was found to have COVID-pneumonia.  Since patient required oxygen, patient was treated with Decadron and remdesivir.  Patient's symptoms improved.  Patient still requires oxygen, therefore, he will be discharged with 2 L nasal cannula.  Patient completed remdesivir 5 days treatment in the hospital.  Patiently discharged with Decadron to complete a 10-day treatment.        Assessment and Plan   COVID pneumonia - Presented with: cough, sob, hypoxia  - Symptom onset: 2/28 - Positive COVID-19: 3/2/23 at ED  - Vaccination status: Vaccinated and boosted X 5.  He also had COVID in 12/2022  - CTPE on admission showed multilobar pneumonia  - Oxygen status: Patient be discharged with 2L nasal cannula O2 - Decadron: Patient be discharged with Decadron to complete 10-day course - Remdesivir: Completed 5-day course in the hospital - Serial COVID labs ordered: yes.  CRP improved (from 104.5 down to 55.6).   Acute hypoxic respiratory failure  -Secondary to above  - CTPA negative for PE but did show multilobar pneumonia  -Patiently discharged with home O2   Recurrent UTI  - pt with recurrent UTI's despite suppressive antibiotics -Urine culture positive for Enterococcus -Patient has been treated with ampicillin while in the hospital.  He will be discharged with Macrobid x7 days.   Common variable immunodeficiency -Follows with Dr. of allergy and immunology -Undergoes IgG infusion every 28 days at home with home health Constipation  Possible history of microscopic colitis - history of c diff, now with constipation  - CTPA shows large stool burden - Constipation has resolved -Continue with MiraLAX and senna twice daily -Daughter will continue to wean entocort as an outpatient    Essential HTN -Continue amlodipine    Dementia -No history of agitation -Not on medications   Chronic thrombocytopenia -Stable   Chronic venous insufficiency with BLE edema -Continue with compression hose
Woke up with severe headache that lasted all day. Late afternoon, developed very low grade fever. Sore arm for 7 days.
2" diameter rash at injection site. The rash is itchy, raised, red, hard and warm to the touch. I first noticed it Sunday evening but it was just a little itchy. It has progressively become bigger but hasn't grown in the past 2 days. It doesn't hurt unless touched and I feel fine otherwise.
Extreme rash over legs arms and stomach  Itchiness  Brushing over legs  Also 103 fever  and fatigue
Pt developed fever, spiking onset, 7 days, post vax. He had urticaria, 8 days, post vax, with irritability, 7 days, post vax. Pt also had the 4th Prevnar vaccination on 9/10/01.
Had massive hair fall event beginning approximately 2 months following event and continued for several months before hair fall began to return to normal.  Acute hair fall event occurred 1&/2 weeks following second dose 9/13 and continued for several weeks. Just now beginning to slow.  Have lost between 60 to 70 percent of  hair at this point.  Also following  2nd dose began to experience intense hot flashes , and loss of period,  and additional hair fall occurred more on crown and part of hair with second "acute" shedding.
45 minutes after vaccination she started to itch all over and noticed that her lips were tingling.
Has pain in shoulder with limited range of motion. Slightly sore after exertion. Never had pain like this before after a shot. Got progressively worse over 2 weeks. Pain is 5/10 with use. Favoring right arm to eliminate pain in left arm.
PATIENT SHOULD HAVE RECEIVED MODERNA SECOND DOSE BUT RECEIVED PFIZER IN ERROR
Cellulitis; Redness; Swelling; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative.  A 65-year-old female patient received the pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on 02May2019 at a single dose for immunization.  Medical history included breast cancer, and type 2 diabetes mellitus; both from an unknown date and unknown if ongoing. Concomitant medications were not reported. On an unspecified date, the patient experienced cellulitis (medically significant), redness, swelling.  The patient went to the emergency room (ER) for symptoms. The clinical outcome of the events was unknown.  The batch/lot numbers for the vaccine, pneumococcal 13-val conj vac (dipht crm197 protein), were not provided and will be requested during follow up.; Sender's Comments: Based on the limited information available the event cellulitis is attributed to an intercurrent medical condition that was unlikely related to suspected vaccine pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13). The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a registered pharmacist concerning a newborn female who on 25-JUN-2010 was vaccinated with 0.5 mL of RECOMBIVAX HB IM (Lot # 666187/1484Y). On approximately 25-JUN-2010 the patient experienced apnea and seizures. On an unknown date, the patient recovered from apnea and seizures. The patient was in the hospital and sought medical attention. The pharmacist wanted to know with the lot check it will be tested if there was overfill or contaminates. Apnea and seizures were considered to be immediately life-threatening. This is one of 4 reports from the same reporter. It was noted that three of the four patients had seizures and one of the four had full arrest. It was unknown what patient had which of the reactions. A lot check has been initiated. Additional information has been requested.
Heavy fatigue all day, the next day after second shot (i.e. Mar 14, 2021).
She started experiencing burning; Rash; Shingles; itching; Headache; Malaise; very tired; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: E13247) via an unspecified route of administration on 19Jan2021 11:30 at a single dose for COVID-19 immunization. Medical history included A-fib. Concomitant medication included apixaban (ELIQUIS). Had COVID-19 Vaccine on 19Jan2021 and everything was fine. Had a headache and a little bit of malaise on 20Jan2021. After two days was ok. On 21Jan2021, broke out in what she thinks was shingles. Not 100% sure if it was a major rash or shingles. Wanted to know if that was a possible side effect. Patient was taking Valaciclovir (VALTREX) for Shingles. Doctor suspected it was shingles, but it was possible she had shingles brewing before the COVID-19 Vaccine or the COVID-19 Vaccine brought the shingles out. Second COVID-19 Vaccine is scheduled for 09Feb2021, patient was scared and afraid of it. Doesn't know what to do. On 20Jan2021 she was very tired and had a headache. Next day was ok. On 21Jan2021 thought she had bug bites. Started itching. Then it began traveling and she realized it was not bug bites. She started experiencing burning. Went to two Urgent Care and her Internist. Was told it was basically shingles. Her internist was on the fence because she just had the COVID-19 Vaccine and wasn't certain. Caller stated it was ironic that she broke out after the vaccine. Caller's internist stated for any rash it would be treated the same with Valtrex. Internist stated chances were the rash was viral so if it's not shingles, would be treated with Valtrex. Rash and Itching: Wasn't very bad on Saturday, 23Jan2021, which was the first time she had someone look at it. On Sunday, 24Jan2021 it was full blown and really blossomed. Was initially treating rash as if it was bug bites. Was applying Benadryl tropical. On Sunday, 24Jan2021, started taking Valtrex. Outcome of the events headache, malaise, fatigue was recovered on n unspecified date, while unknown for the other events.
8 cm x 7 cm slightly raised and red area that is warm to touch on the left deltoid. Left quadrant is tender to touch. Patient states she started w/(L) side/abdominal pain and fall asleep after work. When she woke up this morning is when she noted this red raised area on (L) deltoid-states it has not changed in size or color, currently 1320.
It did hurt my arm; Made me a bit under the weather; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: It did hurt my arm) and feeling unwell (Verbatim: Made me a bit under the weather). The outcome of the pain in arm and feeling unwell were resolved.   It was unknown if the reporter considered the pain in arm and feeling unwell to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm and feeling unwell to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that the shingles vaccine hurt her arm and made her a bit under the weather for a few days. The follow-up could not be possible as no contact details were available.
Given shot 8:15 - 3 hrs 11:15 later - sx fast breathing & difficult catching breath (accelerated fast) - went to hospital w/ friend - admitted w/ oxygen & NTG-nitroglycerin (O2 level was low) stress test fine - 1 day in hospital.
a tingling sensation in lips and tongue; heart racing; unable to sleep all night; Weakness; Diarrhea; fight or flight sensation/adrenaline rush sensation; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (a tingling sensation in lips and tongue), PALPITATIONS (heart racing), INSOMNIA (unable to sleep all night), ASTHENIA (Weakness) and DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced PARAESTHESIA ORAL (a tingling sensation in lips and tongue), PALPITATIONS (heart racing), INSOMNIA (unable to sleep all night), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), FEELING ABNORMAL (fight or flight sensation/adrenaline rush sensation), PYREXIA (Fever) and FATIGUE (Fatigue).   At the time of the report, PARAESTHESIA ORAL (a tingling sensation in lips and tongue), PALPITATIONS (heart racing), INSOMNIA (unable to sleep all night), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), FEELING ABNORMAL (fight or flight sensation/adrenaline rush sensation), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Beginning on day 13-14 after injection, mild numbness from injection point to finger tips. Lasting to present.
Patient administered expired vaccine on date 03-Feb-2022 which was continuously stored in stable freezer environment. Only stored in fridge on date of administration for thaw period; 1 Expired Dose administered on 03-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 Expired Dose administered on 03-Feb-2022) and PRODUCT STORAGE ERROR (Patient administered expired vaccine on date 03-Feb-2022 which was continuously stored in stable freezer environment. Only stored in fridge on date of administration for thaw period) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (1 Expired Dose administered on 03-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient administered expired vaccine on date 03-Feb-2022 which was continuously stored in stable freezer environment. Only stored in fridge on date of administration for thaw period). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 Expired Dose administered on 03-Feb-2022) and PRODUCT STORAGE ERROR (Patient administered expired vaccine on date 03-Feb-2022 which was continuously stored in stable freezer environment. Only stored in fridge on date of administration for thaw period) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported
Pt had a tonic clinic seizure in the observation area. Pt was brought to the ground and EMS called. Vital signs stable. Cold compress to forehead .  Transported to hospital.
04/04/04 developed intussusception; required air enema for reduction. Became fussy and gassy 4/1/04.
She developed hives over trunk & extremities 20 minutes after receiving vaccine. Used Encenin hives gone in 45 minutes.
Patient first showed outwards signs of illness on May 11, 2021--fever, lethargy.  We thought these were normal side-effects of the Covid vaccine, so did not take patient to hospital, until May 14, when patient began to lose his hearing, and was losing his balance.  He was taken to the Emergency Room, at approximately 4:30 PM.  Within a few hours, he was taken to the UCI.  His diagnosis:  captnocytophagia bacteremia and septic shock with purpura fulminans, thrombocytopenia and multiorgan failure.
This is a spontaneous report from a contactable consumer (mother). A male patient of unspecified age and ethnicity/race received in May2016 first single dose of TRUMENBA and MENACTRA, both for immunization. Medical history and concomitant medications were not reported. On an unspecified date in 2016 (reported as several days later), the patient broke out in very large hives probably 4 inches which lasted a little over 2 days kind of coming and going. Patient was on a three dose regimen for the meningococcal group b rlp2086 and the mother was wondering if son should go forward and get the second and third doses of meningococcal group b rlp2086. Final outcome was unknown.
Child was given 0.2ml dose of undiluted Pfizer 5-12 year old vaccine.  This was the child's second dose of Pfizer vaccine.  Parent was contacted on 1/26/2022 and child was experiencing fever, chills, achiness, and site pain.  No other reactions experienced up to that date/time of contact.
Fever of 100.9; Having extreme body aches; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd February 2021, the patient received the 2nd dose of Shingrix. In February 2021, less than a week after receiving Shingrix, the patient experienced fever and general body pain. On an unknown date, the outcome of the fever and general body pain were not recovered/not resolved.   It was unknown if the reporter considered the fever and general body pain to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient experienced extreme body aches and fever was 100.9. The reporter asked if was it ok. The follow-up would not possible, as no contact details were available.
limp episode w/rolling back of eyes for 30sec 2hr p/vax;
Cough; 2nd dose of vaccine is scheduled for more than 35 days after 1st dose; symptoms of COVID; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (symptoms of COVID), COUGH (Cough) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine is scheduled for more than 35 days after 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) and BENZONATATE for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced MALAISE (symptoms of COVID). On an unknown date, the patient experienced COUGH (Cough) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine is scheduled for more than 35 days after 1st dose). At the time of the report, MALAISE (symptoms of COVID) and COUGH (Cough) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine is scheduled for more than 35 days after 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, SARS-CoV-2 test negative: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Subject passed-out for about 20 seconds, 5 minuets after injection.  Approx. 24 to 36 hours later began experiencing intermittent chest pains  and rapid heart beats. This has continued for the last 8 days.
Not sure when but patient came back to pharmacy after receiving the vaccine and complained of arm pain near the point of injection.
Development of 2 little red dots on face Thursday night. Friday-rash around mouth- Blister on lips. Friday night went to ER. Amoxil 1 tsp prescribed by ER physician.
Patient complained of pain, itchiness and redness spreading throughout her right arm. Patient was admitted to the emergency a week later. Blood test showed there were signs of cellulitis. Patient was prescribed KEFLEX 250mg on 3/24/19. According to the daughter, patient feels better but still complains of itchiness and pain. The redness still has not gone away yet.
Time 8:05 pt started to cough c/o of c/o of chest pain , lip numbness 911 called vital taken  Dr. called to assess pt , after assessment pt stated she was feeling better  Paramedics arrived and pt stated to c/o Nausea and started to vomit , pt taken transferred to ER via Paramedics
Itching, the pain in shoulder, then shaking and brain zaps, the pain in whole left arm, then more shaken and brain zaps, then pain from left elbow to left side of neck progressing over seven days time. Pain in right eye.
This spontaneous report as received from health care worker refers to approximately 2 year old female patient. No information provided regarding concurrent conditions and medical history reported. On 11-JAN-2012 the patient was vaccinated with GARDASIL dose 2 (dosage, route, lot # not reported). Prior to this the patient was vaccinated with GARDASIL on 26-OCT-2011. No concomitant medications reported. The health care professional reported that the patient was at teh office to receive third dose of GARDASIL at the time of the report and no adverse effect reported. Additional information has been requested.
Pain in ankle starting 12/3/13. The next day she developed tingling, burning in both legs. She developed weakness, decreased reflexes and restless legs and was sent to the ER 12-9-13 spinal fluid showed elevated protein and IVIG treatment given.
Onset of neck tightness, tingling, difficulty swallowing, reported angioedema of soft palate, nausea. Sent to ER via wheelchair with ongoing sensation of choking and one episode of vomiting. Sensation of difficulty breathing. Administration of epipen upon arrival to ER. Following this, VSS and no further noted angioedema. Overall began to feel better. Additionally treated with solumedrol, benadryl and pepcid. No rash at any point. No labs drawn. Observed x 5 hours with no return of sx.